Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study

Erstveröffentlichung

2019

Authors

Clemens, Eva

Meijer, Annelot J. M.

Broer, Linda

Langer, Thorsten

van der Kooi, Anne-Lode L. F.

et al.

Wissenschaftlicher Artikel

Published in

JMIR Research Protocols ; 8 (2019), 3. - Art.-Nr. e11868. - ISSN 1929-0748

Link to publication

https://dx.doi.org/10.2196/11868

Institutions

UKU. Institut für Naturheilkunde und Klinische Pharmakologie

Subject headings

[Free subject headings]: ototoxicity | hearing loss | childhood cancer survivors | cisplatin | genetics | GWAS | candidate genes | polymorphisms | CISPLATIN-INDUCED OTOTOXICITY | INDUCED HEARING-LOSS | PLATINUM-INDUCED OTOTOXICITY | INTERNATIONAL SOCIETY | CHILDREN | VARIANTS | TPMT | CHEMOTHERAPY | SURVIVORS | ACYP2
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record